Phase II Trial Evaluating the Safety and Efficacy of the Combination of Zimberelimab, Domvanalimab and Sacituzumab Govitecan as 1L Therapy for PD-L1 Positive Advanced TNBC
Clinical trial NCT07134556 · WITHDRAWN
Trial details
- NCT number
- NCT07134556
- Sponsor
- MedSIR
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2028-05-28
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.